ABAlmudena Burillo

Almudena Burillo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Almudena Burillo has a total of 199 co-authors. Here are the top co-authors by number of shared publications:

  • Emilio Bouza

    Department of Clinical Microbiology and Infectious Diseases; Gregorio Marañón Institute of Health Research (IiSGM); Department of Medicine, Faculty of Medicine, Complutense University. Madrid, Spain

    44 shared publications
  • Patricia Muñoz

    Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain

    25 shared publications
  • Emilio Bouza

    Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón , Madrid

    7 shared publications
  • María Jesús Pérez-Granda

    Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    7 shared publications
  • José Luis Gómez-Garcés

    Hospital Universitario de Móstoles, C/Río Júcar, s/n, Móstoles, 28935 Madrid, Spain

    5 shared publications
  • Javier Hortal

    Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; CIBER de Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain; Cardiac Surgery Postoperative Care Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    4 shared publications

Latest Publications

  • Impact of early microbiology laboratory activation on rapid diagnosis and antimicrobial optimization in a sepsis alert pathway

    by A. Álvarez-Uría, S. de la Villa, A. Estévez, A. Burillo, M. Sancho, M. Ferris Villanueva, B. Torroba-Sanz, E. Bouza, P. Muñoz

  • Open Access

    Clinical impact of a rapid urine diagnostic algorithm combined with antimicrobial stewardship in patients with suspected urinary sepsis

    by Almudena Burillo, Belén Rodríguez-Márquez, Ana Álvarez-Uría, Lara Vesperinas, Patricia Muñoz, Emilio Bouza

    Introduction: Early appropriate antimicrobial therapy is a key determinant of outcome in sepsis, yet conventional urine culture takes 24–48 hours. We evaluated the clinical impact of a rapid microbiological algorithm applied directly to urine, combined with antimicrobial stewardship, in patients with suspected urinary sepsis. Methods: Prospective quasi-experimental two-phase cohort study at a tertiary hospital. In adults with simultaneous urine and blood cultures, an initial observational phase formed the comparison cohort (conventional culture), and a second phase the intervention cohort, in which urine underwent Gram stain, laser-nephelometry growth detection (Alfred 60/AST), MALDI-TOF-MS identification, rapid susceptibility testing, and immunochromatographic ESBL and carbapenemase detection, with immediate reporting and recommendations by an infectious diseases specialist. Multivariable models (logistic and negative binomial) were adjusted for age, sex, Charlson index, department and qSOFA. Results: We included 594 patients (297 per cohort). The algorithm achieved organism identification in 92.6% of cases, with a median turnaround time of 7.25 versus 75.0 hours (p<0.001), and 98.6% agreement with culture. Overall mortality was 6.1% versus 11.1% (p=0.039). After adjustment, the intervention was associated with significant reductions in hospital stay (IRR 0.82; p=0.012), days of therapy (IRR 0.79; p<0.001), intravenous antibiotics (IRR 0.83; p=0.001), need for ICU admission (OR 0.42; p=0.003) and overall mortality (OR 0.44; p=0.011). Conclusions: A rapid urine diagnostic algorithm, integrated with an expert stewardship intervention, was associated with lower antibiotic consumption and improved outcomes in suspected urinary sepsis. Combining rapid diagnostics with expert advice appears key to translating microbiological information into effective therapeutic decisions.

  • Open Access

    Evaluation of Quantitative Differences of Classic Methods, Fungal Biomarkers, and T2Candida for Assessing the Central Venous Catheter Origin of Candidemia

    by Ana Soriano-Martín, Antonio Vena, María Jesús Pérez-Granda, Alessandro Limongelli, Almudena Burillo, Pilar Escribano, Jesús Guinea, Malgorzata Mikulska, Daniele Roberto Giacobbe, Marina Machado, et al.

    Background: This study was conducted to investigate the diagnostic value of fungal biomarker differentials and T2Candida polymerase chain reaction (PCR) from catheter and peripheral blood samples and to re-evaluate classical conservative methods, such as differential time to positivity of blood cultures (BCs), for the early identification of catheter-related candidemia (CRC) before catheter removal. Methods: This prospective study was conducted (March 2023–April 2025) in 2 tertiary hospitals in Spain and Italy. Adults (aged ≥18 years) with candidemia and a central venous catheter in place at diagnosis were included, provided catheter removal occurred within 48 hours of index BC positivity. CRC was defined in patients with candidemia who showed 1 or 2 of the following criteria in the catheter tip: (1) ≥ 15 CFU/plate (Maki technique) or ≥ 1000 CFU/mL (sonication) and (2) any Candida growth on the catheter tip. Blood samples were collected from peripheral veins and catheter lumens to compare the differentials of 1,3-β-D-glucan (BDG), Candida albicans germ tube antibodies, mannan antigen, antimannan antibody, and T2Candida PCR results. Diagnostic metrics were calculated for each test. Results: Of 179 episodes of candidemia reviewed, 28 (15.6%) met the inclusion criteria (13 in Spain, 15 in Italy). CRC was confirmed in 11 patients (39.3%) using criterion 1 and in 15 patients (53.6%) using criterion 2. BDG differentials (any difference) demonstrated the highest diagnostic accuracy as follows: sensitivity 81.82%, specificity 82.35%, positive predictive value 75.00%, negative predictive value 87.50%, and overall accuracy 82.14% (criterion 1). However, stricter BDG thresholds (≥20 or ≥30 pg/mL) and the application of criterion 2 reduced the sensitivity. Other biomarkers and T2Candida PCR demonstrated low sensitivity (0%–40%) and variable specificity (25%–100%), with overall accuracies of <64%. Differential time to positivity of BCs yielded a sensitivity of 72.73% and a specificity of 52.94%, with limited accuracy. Conclusions: None of the investigated methods achieved sufficient accuracy to diagnose CRC without catheter removal. Despite the limited sample size, this study emphasizes the limitations of current diagnostic approaches and the need for novel tools for reliable noninvasive identification of CRC.

  • Open Access

    Situation and questions regarding the practice of blood cultures in paediatric patients: an opinion paper

    by Almudena Burillo, Agustín Estévez, Martha Kestler, María Jesús Pérez-Granda, Patricia Muñoz, Emilio Bouza

    The collection and interpretation of blood cultures in paediatric patients require specific considerations that make simple extrapolation from adult recommendations inappropriate. In recent years, the incidence and aetiology of paediatric bacteraemia have evolved, influenced by vaccination programmes, improved infection prevention strategies, and increasing clinical complexity, particularly in neonatal, oncohaematological, and intensive care settings. Clinical guidelines recommend blood cultures in neonates and infants with fever without a focus in children with sepsis or shock, with immunosuppression, suspected endovascular infection, meningitis, osteoarticular infections, or severe community-acquired pneumonia. Conversely, routine use is discouraged in clearly viral infections and in mild cases in previously healthy children. Available evidence consistently identifies the volume of blood inoculated as the main determinant of diagnostic performance, and this should be adjusted for age and weight. Obtaining one or two appropriately indicated peripheral blood culture sets, together with proper antisepsis, reduces contamination and improves clinical interpretation. Whenever feasible, both aerobic and anaerobic bottles should be included, given their complementary diagnostic yield. There is no robust evidence that paediatric bottles with smaller broth volumes provide substantial advantages over standard bottles when adequate blood volumes are inoculated. Importantly, no evidence demonstrates that the type of bottle or automated system used influences hospital stay, clinical outcomes, or mortality. This article presents an evidence-informed perspective that integrates current literature with expert clinical judgment, derived from more than four decades of experience at a high-complexity tertiary-care hospital.

  • Is Time to Positivity in Staphylococcus aureus Bacteremia a Harbinger of Endocarditis?

    by Anna Tonizzo, Patricia Muñoz, Almudena Burillo, Iván Adán, Luis Alcalá, Emilio Bouza


  • Open Access

    Diagnostic and prognostic value of time to positivity in blood cultures. An opinion paper

    by Paola Maffezzoli, Martha Kestler, Almudena Burillo, Silvia Corcione, Francesco Giuseppe De Rosa, Patricia Muñoz, Emilio Bouza

    Time to positivity (TTP) refers to the duration required for a microbiological culture test to indicate a positive result, marking the onset of detectable bacterial or fungal growth in the sample. Numerous variables, including patient characteristics, infection source, former antimicrobial therapy, blood sample volume, and sample transportation time can influence the value of TTP. Several studies have been conducted on bloodstream infections, whereas studies on the clinical significance of yeast TTP are quite limited in the literature. Furthermore, many studies are retrospective and have a small sample size. In this opinion paper, we have formulated some questions and attempted to provide answers based on the available literature and our perspective. The objective of this opinion paper is to summarise current knowledge based on the literature, aiming to offer a critical perspective, particularly on aspects with weaker evidence, which could guide future studies in this area. We believe that TTP of blood cultures appears to exhibit considerable potential and may prove to be a valuable tool in clinical practice for estimating patient mortality risk and guiding antimicrobial therapy choices. Topics discussed include the diagnostic and prognostic role of TTP in Gram-positive and Gram-negative bacteremias and in candidemias, and the significance of differential time to positivity (DTTP). In summary, our opinion is that, based on the available literature, it is not possible to determine whether TTP provides prognostic information, particularly concerning candidemia. Therefore, clinical decisions cannot be systematically based on this parameter.


  • Open Access

    Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain

    by Mari Cruz Martín-Delgado, Pilar De Lucas Ramos, Alejandra García-Botella, Rafael Cantón, Alberto García-Lledó, Teresa Hernández-Sampelayo, Javier Gómez-Pavón, Juan González del Castillo, Francisco Javier Martín Sánchez, Manuel Martínez-Sellés, et al.

    Group A ß-hemolytic Streptococcus (S. pyogenes), also known as GAS, is a Gram-positive bacterium. It can be easily identified in the microbiology laboratory by its ability to hemolyse blood in culture media. This bacterium is highly virulent due to its production of enzymes and toxins, and its ability to cause immunologically mediated diseases such as rheumatic fever and post-streptococcal glomerulonephritis. GAS is the primary cause of bacterial pharyngotonsillitis, although it is typically a benign and non-invasive disease. However, it also has the potential to cause severe skin and soft tissue infections, necrotising fasciitis, bacteraemia and endocarditis, pneumonia and empyema, and streptococcal toxic shock syndrome, without any age or predisposition limits. The term invasive GAS disease (iGAS) is used to refer to this group of conditions. In more developed countries, iGAS disease has declined thanks to improved hygiene and the availability of antibiotics. For example, rheumatic fever has practically disappeared in countries such as Spain. However, recent data suggests a potential increase in some iGAS diseases, although the accuracy of this data is not consistent. Because of this, the COVID and Emerging Pathogens Committee of the Illustrious Official College of Physicians of Madrid (ICOMEM) has posed several questions about invasive GAS infection, especially its current situation in Spain. The committee has enlisted the help of several experts in the field to answer these questions. The following lines contain the answers that we have collaboratively produced, aiming to assist not only the members of ICOMEM but also anyone interested in this topic.


  • How to manage skin and soft-tissue infections in the emergency department

    by Emilio Bouza, Almudena Burillo, Patricia Muñoz

    Purpose of review: Our purpose is to review the state-of-the-art on the management of skin and soft tissue infections (SSTI) in emergency departments (ED). Although the information is scarce, SSTI may account for 3–30% of all cases presenting to an ED, of which 25–40% require hospital admission. SSTI include very different entities in aetiology, location, pathogenesis, extension, and severity. Therefore, no single management can be applied to them all. A simple approach is to classify them as non-purulent, purulent, and necrotising, to which a severity scale based on their systemic repercussions (mild, moderate, and severe) must be added. The initial approach to many SSTIs often requires no other means than anamnesis and physical examination, but imaging tests are an indispensable complement in many other circumstances (ultrasound, computerized tomography, magnetic resonance imaging…). In our opinion, an attempt at etiological filiation should be made in severe cases or where there is suspicion of a causality other than the usual one, with tests based not only on cultures of the local lesion but also molecular tests and blood cultures. Recent findings: Recent contributions of interest include the value of bedside ultrasound and the potential usefulness of biomarkers such as thrombomodulin to differentiate in early stages the presence of necrotising lesions not yet explicit. New antimicrobials will allow the treatment of many of these infections, including severe ones, with oral drugs with good bioavailability and for shorter periods. Summary: The ED has an essential role in managing SSTIs, in their classification, in decisions on when and where to administer antimicrobial treatment, and in the rapid convening of multidisciplinary teams that can deal with the most complex situations.


  • Open Access

    Value of syndromic panels in the management of severe community-acquired pneumonia

    by Almudena Burillo, Francisco Javier Candel, Andrés Canut-Blasco

    Community-acquired pneumonia requiring hospital admission is a prevalent and potentially serious infection, especially in high- risk patients (e.g., those requiring ICU admission or immunocompromised). International guidelines recommend early aetiological diagnosis to improve prognosis and reduce mortality. Syndromic panels that detect causative pathogens by molecular methods are here to stay. They are highly sensitive and specific for detecting the targets included in the test. A growing number of studies measuring their clinical impact have observed increased treatment appropriateness and decreased turnaround time to aetiological diagnosis, need for admission, length of hospital stay, days of isolation, adverse effects of medication and hospital costs. Its use is recommended a) per a pre-established protocol on making the diagnosis and managing the patient, b) together with an antimicrobial stewardship programme involving both the Microbiology Service and the clinicians responsible for the patient, and c) the final evaluation of the whole process. However, we recall that microbiological diagnosis with traditional methods remains mandatory due to the possibility that the aetiological agent is not included among the molecular targets and to determine the antimicrobial susceptibility of the pathogens detected.


  • Faster infection diagnostics for intensive care unit (ICU) patients

    by Almudena Burillo, Emilio Bouza

    The patient admitted to intensive care units (ICU) is critically ill, to some extent immunosuppressed, with a high risk of infection, sometimes by multidrug-resistant microorganisms. In this contex...